药用β-内酰胺类抗生素的研究。IV. 6-[D(-)-α-(4-乙基-2,3-二氧代-1-哌嗪甲酰胺基)苯乙酰氨基]青霉烷酸（T-1220）在水溶液和体液中的稳定性（作者译） - Suppr | 超能文献

[Studies on beta-lactam antibiotics for medicinal purpose. IV. Stability of 6-[D(-)-alpha-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)phenylacetamido)penicillanic acid (T-1220) in aqueous solution and body fluid (author's transl)].

作者信息

Saikawa I, Takano S, Yoshida C, Saito E, Yasuda T

出版信息

Yakugaku Zasshi. 1977 Sep;97(9):995-1001. doi: 10.1248/yakushi1947.97.9_995.

DOI:10.1248/yakushi1947.97.9_995

PMID:21947

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

[Studies on beta-lactam antibiotics for medicinal purpose. IV. Stability of 6-[D(-)-alpha-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)phenylacetamido)penicillanic acid (T-1220) in aqueous solution and body fluid (author's transl)].药用β-内酰胺类抗生素的研究。IV. 6-[D(-)-α-(4-乙基-2,3-二氧代-1-哌嗪甲酰胺基)苯乙酰氨基]青霉烷酸（T-1220）在水溶液和体液中的稳定性（作者译）

Yakugaku Zasshi. 1977 Sep;97(9):995-1001. doi: 10.1248/yakushi1947.97.9_995.

2

[Studies on beta-lactam antibiotics for medicinal purpose. V. Structure of degradation products of 6-[D(--)-alpha-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)phenylacetamido]penicillanic acid (T-1220) in aqueous solution (author's transl)].药用β-内酰胺类抗生素的研究。V. 6-[D（-）-α-（4-乙基-2,3-二氧代-1-哌嗪甲酰胺基）苯乙酰胺基]青霉烷酸（T-1220）在水溶液中的降解产物结构（作者译）

Yakugaku Zasshi. 1977 Oct;97(10):1064-70. doi: 10.1248/yakushi1947.97.10_1064.

3

[Studies on beta-lactam antibiotics for medicinal purpose. VII. Synthesis of 6-[D-alpha-(5 and 6-alkyl-4-ethyl-2,3-dioxo-1-piperazinecarboxamido)phenylacetamido]-penicillanic acids and structure-antibacterial activity (author's transl)].药用β-内酰胺抗生素的研究。VII. 6-[D-α-(5和6-烷基-4-乙基-2,3-二氧代-1-哌嗪甲酰胺基)苯乙酰胺基]青霉烷酸的合成及结构-抗菌活性（作者译）

Yakugaku Zasshi. 1979 Apr;99(4):371-9. doi: 10.1248/yakushi1947.99.4_371.

4

[Studies on beta-lactam antibiotics for medicinal purpose. VI. Studies on the metabolism of 6-[D(--)-alpha-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-phenylacetamido]penicillanic acid (T-1220) (author's transl)].药用β-内酰胺抗生素的研究。VI. 6-[D（-）-α-（4-乙基-2,3-二氧代-1-哌嗪甲酰胺基）苯乙酰氨基]青霉烷酸（T-1220）的代谢研究（作者译）

Yakugaku Zasshi. 1977 Oct;97(10):1071-81. doi: 10.1248/yakushi1947.97.10_1071.

5

[Studies on beta-lactam antibiotics for medicinal purpose. X. Stability and degradation pattern of sodium 7-[D(--)-alpha-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-alpha-(4-hydroxyphenyl)acetamido]-3-[(1-methyl-1H-tetrazol-5-yl)thiomethyl]-3-cephem-4-carboxylate (T-1551) in aqueous solution (author's transl)].药用β-内酰胺类抗生素的研究。X. 7-[D(-)-α-(4-乙基-2,3-二氧代-1-哌嗪甲酰胺基)-α-(4-羟基苯基)乙酰胺基]-3-[(1-甲基-1H-四氮唑-5-基)硫甲基]-3-头孢烯-4-羧酸酯钠（T-1551）在水溶液中的稳定性及降解模式（作者译）

Yakugaku Zasshi. 1979 Dec;99(12):1207-18. doi: 10.1248/yakushi1947.99.12_1207.

6

[Studies on beta-lactam antibiotics for medicinal purpose. III. Structure-activity relationship of 6-[D(-)-alpha-(4-alkyl-2,3-dioxo-1-piperazinecarbox-amido)phenylacetamido]penicillanic acids (author's transl)].用于医疗目的的β-内酰胺抗生素的研究。III. 6-[D(-)-α-(4-烷基-2,3-二氧代-1-哌嗪甲酰胺基)苯乙酰胺基]青霉烷酸的构效关系（作者译）

Yakugaku Zasshi. 1977 Sep;97(9):987-94.

7

[Studies on beta-lactam antibiotics for medicinal purpose. XIV. Stability and degradation pattern of sodium 7 beta-[(2R, 3S)-2-(4-ethyl-2, 3-dioxo-1-piperazinecarboxamido)-3-hydroxybutanamido]-7 alpha-methoxy-3-[(1-methyl-1H-tetrazol-5-yl)thiomethyl]-3-cephem-4- carboxylate (T-1982) in aqueous solution].[药用β-内酰胺抗生素的研究。十四。7β-[(2R,3S)-2-(4-乙基-2,3-二氧代-1-哌嗪甲酰胺基)-3-羟基丁酰胺基]-7α-甲氧基-3-[(1-甲基-1H-四氮唑-5-基)硫甲基]-3-头孢烯-4-羧酸钠（T-1982）在水溶液中的稳定性及降解模式]

Yakugaku Zasshi. 1983 Jan;103(1):62-72. doi: 10.1248/yakushi1947.103.1_62.

8

[Studies on beta-lactam antibiotics for medicinal purpose. VIII. Synthesis of 7-[D(-)-alpha-(4-alkyl-2,3-dioxo-1-piperazinecarboxamido)phenylacetamido]-cephalosporanic acids and structure-antibacterial activity (author's transl)].药用β-内酰胺类抗生素的研究。VIII. 7-[D(-)-α-(4-烷基-2,3-二氧代-1-哌嗪甲酰胺基)苯乙酰胺基]-头孢烷酸的合成及结构-抗菌活性（作者译）

Yakugaku Zasshi. 1979 Sep;99(9):929-35. doi: 10.1248/yakushi1947.99.9_929.

9

[Studies on beta-lactam antibiotics for medicinal purpose. XI. Studies on the metabolism of sodium 7-(D(-)-alpha-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-alpha-(4-hydroxyphenyl)acetamido)-3-((1-methyl-1H-tetrazole-5-yl)thiomethyl)-3-cephem-4-carboxylate (T-1551) (author's transl)].用于医学目的的β-内酰胺类抗生素研究。十一。7-（D（-）-α-（4-乙基-2,3-二氧代-1-哌嗪甲酰胺基）-α-（4-羟基苯基）乙酰胺基）-3-（（1-甲基-1H-四氮唑-5-基）硫甲基）-3-头孢烯-4-羧酸酯钠（T-1551）的代谢研究（作者译）

Yakugaku Zasshi. 1980 Jun;100(6):625-40.

10

[Absorption, excretion and distribution of 14C-labelled 6-[D(-)-alpha-(4-ethyl-2, 3-dioxo-1-piperazinecarboxamido)-alpha-phenylacetamido] penicillanic acid (14C-T-1220) in rats and mice (author's transl)].14C标记的6-[D(-)-α-(4-乙基-2,3-二氧代-1-哌嗪甲酰胺基)-α-苯乙酰胺基]青霉烷酸（14C-T-1220）在大鼠和小鼠体内的吸收、排泄及分布（作者译）

Jpn J Antibiot. 1977 Aug;30(8):571-81.

引用本文的文献

1

Tobramycin inactivation by carbenicillin, ticarcillin, and piperacillin.羧苄西林、替卡西林和哌拉西林对妥布霉素的灭活作用。

Antimicrob Agents Chemother. 1983 May;23(5):653-7. doi: 10.1128/AAC.23.5.653.